Drug class in one race
GLP-1/glucagon receptor (dual) drugs for MASH / NASH
3 tracked GLP-1/glucagon receptor (dual) drugs in the MASH / NASH race. The class explanation lives on the GLP-1/glucagon receptor (dual) page; the full indication pipeline across every mechanism is on the MASH / NASH page.
2 Phase 31 Phase 1/2
Head-to-head evidence: OPK-88006 vs pemvidutide · OPK-88006 vs survodutide · pemvidutide vs survodutide